Stay updated with breaking news from Decision Resources. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Expansion into Immunology with New Discovery Program of Oral KIT Inhibitors Addressing High Unmet Need in Chronic Spontaneous Urticaria ; Development Candidate Selection Targeted for 2024 Expect...
Paris, September11, 2023 - I am pleased to announce that DrBonnie Bain, PhD has been appointed Global Head of Healthcare and will join us on 11th ...
Infor has announced a partnership with longtime customer Brentwood Industries to revamp and modernize its business processes
Comprehensive clinical development program called QUANTI includes two Phase III studies in adults and one pediatric study investigating gadoquatrane for use in MRI across all body regions and across ages from birth to adulthoodÂ
/PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced positive topline results from its Phase 2b FRONTIER 1 clinical trial...